Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil

Am J Kidney Dis. 1999 Feb;33(2):301-3. doi: 10.1016/s0272-6386(99)70304-5.

Abstract

We examined the effect of different doses of calcium channel blockers on plasma cyclosporine levels. As previously reported by multiple investigators, we observed that the administration of verapamil or diltiazem, but not nifedipine or isradipine, caused a significant increase in plasma cyclosporine levels achieved for a given dose of cyclosporine. In this article, we show that the effect of verapamil and diltiazem on cyclosporine levels appears to be independent of dosage within their usual prescription range.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Calcium Channel Blockers / administration & dosage*
  • Calcium Channel Blockers / pharmacology*
  • Cyclosporine / administration & dosage
  • Cyclosporine / blood*
  • Diltiazem / administration & dosage
  • Diltiazem / pharmacology
  • Dose-Response Relationship, Drug
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / blood*
  • Isradipine / administration & dosage
  • Isradipine / pharmacology
  • Medical Records
  • Nifedipine / administration & dosage
  • Nifedipine / pharmacology
  • Radioimmunoassay
  • Retrospective Studies
  • Verapamil / administration & dosage
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Immunosuppressive Agents
  • Cyclosporine
  • Verapamil
  • Diltiazem
  • Nifedipine
  • Isradipine